missing translation for 'onlineSavingsMsg'
Learn More
Learn More
1,2-Bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazine, TRC
Specifications
Specifications
| Nom chimique ou matériau | Irganox 1024 |
| CAS | 32687-78-8 |
| Formule moléculaire | C34 H52 N2 O4 |
| Quantité | 5 g |
| Synonyme | Hydrazine, 1,2-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)- (8CI), 1,2-Bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazide, 1,2-Bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazine, 1,2-Bis(3,5-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazine, 3,5-Bis(1,1-dimethylethyl)-4-hydroxybenzenepropionic acid 2-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropyl]hydrazide, ADK Stab CDA 10, Antioxidant 1024, Antioxidant BPP, CDA 10, IR 1024, Irganox 1024, Irganox GX MD 1024, Irganox MD 1024, Irganox MD 2014, Lowinox MD 24, MD 1024, MD 24, N,N'-Bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyl]hydrazine, N,N'-Bis[3-(3',5'-di-tert-butyl-4'-hydroxyphenyl)propionyl]hydrazine, N,N'-Bis[β-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid] hydrazide, N,N'-Bis[β-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyl]hydrazine, Songnox 1024, Songnox 1024FG, Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 2-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropyl]hydrazide |
| Formule InChI | InChI=1S/C34H52N2O4/c1-31(2,3)23-17-21(18-24(29(23)39)32(4,5)6)13-15-27(37)35-36-28(38)16-14-22-19-25(33(7,8)9)30(40)26(20-22)34(10,11)12/h17-20,39-40H,13-16H2,1-12H3,(H,35,37)(H,36,38) |
| SMILES | CC(C)(C)c1cc(CCC(=O)NNC(=O)CCc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)cc(c1O)C(C)(C)C |
| Nom IUPAC | 3-(3,5-ditert-butyl-4-hydroxyphényl)-N'-[3-(3,5-ditert-butyl-4-hydroxyphényl)propanoyl]propanehydrazide |
| Poids moléculaire (g/mol) | 552.7877 |
| Poids de la formule | 552.3927 |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?